Scientific review focuses on hypoxia-inducible factors
The biochemical mechanisms that control the stabilization of hypoxia-inducible factors (HIFs) and the molecular strategies that can be exploited pharmacologically to promote or inhibit HIFs are the focus of a new scientific review published by faculty in the Department of…
Research explores novel therapies for IRI
A four-year, $2.6 million grant to study circadian rhythm and novel therapies to protect the heart during a heart attack or cardiac surgery has been awarded to UTHealth Houston by the National Heart, Lung, and Blood Institute, part of the…
Pages